4//SEC Filing
Feller Faye 4
Accession 0000950170-24-072420
CIK 0000886744other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:05 PM ET
Size
15.6 KB
Accession
0000950170-24-072420
Insider Transaction Report
Form 4
GERON CORPGERN
Feller Faye
EVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-06-10−112,500→ 87,500 totalExercise: $1.06Exp: 2032-02-15→ Common Stock (112,500 underlying) - Exercise/Conversion
Common Stock
2024-06-10$1.06/sh+112,500$119,250→ 112,500 total - Sale
Common Stock
2024-06-10$4.63/sh−287,900$1,334,129→ 0 total - Exercise/Conversion
Common Stock
2024-06-10$1.29/sh+155,400$201,243→ 155,400 total - Exercise/Conversion
Stock Option (right to buy)
2024-06-10−20,000→ 0 totalExercise: $1.06Exp: 2032-02-15→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2024-06-10$1.06/sh+20,000$21,200→ 20,000 total - Exercise/Conversion
Stock Option (right to buy)
2024-06-10−155,400→ 0 totalExercise: $1.29Exp: 2030-02-11→ Common Stock (155,400 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]This option vests in a series of 48 consecutive equal monthly installments commencing February 16, 2022 (of which 112,500 shares were vested as of the exercise date), provided the optionee continues to provide services to the Company.
- [F3]Option fully vested.
Documents
Issuer
GERON CORP
CIK 0000886744
Entity typeother
Related Parties
1- filerCIK 0001937361
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:05 PM ET
- Size
- 15.6 KB